Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review is a research paper published in Thrombosis Research (2023). On theSindex it has a DataRank of 0.493. It has been cited 13 times, with 12 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0.0967
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 12 citers.
National Heart, Lung, and Blood Institute
Grant: 1K23HL159313
NHLBI NIH HHS
Grant: K23 HL159313
American Society of Hematology
National Institutes of Health
FWCI
2.15
Citation Percentile
0.9%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals